Cell Biotech Co., Ltd. engages in the manufacture, research and development of probiotics lactobacillus products. Its products include probiotics, probiotic-related products, health functional food, general food, cleansing foam and bio-active cream for skin, and raw material probiotic products. The company was founded on February 7, 1995 and is headquartered in Gimpo-si, South Korea.

Luminor Medical Technologies is a medical diagnostic company, focuses on acquiring, developing, and commercializing non-invasive tests for unmet clinical needs in Canada. The company’s products and services include PREVU Skin Cholesterol Test, a non-invasive test that measures cholesterol in the skin tissues to assess risk of coronary artery disease or heart disease; PSP94, an enzyme linked immunosorbent assay for urine specimens; and testing services. Its diagnostic programs under development comprise cardiovascular disease, preeclampsia, prostate cancer, colorectal cancer, pancreatic cancer, and gastric cancer programs. The company has a partnership agreement with Alere, Inc. for the development of tests for preeclampsia biomarkers.

Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not Allocated Assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases. The company's lead programs target patients with rare genetic metabolic diseases, including phenylketonuria and secondary hyperoxaluria. Synlogic is also hard at work on synthetic biotics to address more prevalent conditions, including inflammatory bowel disease, cancer, and other metabolic conditions.

Hisamitsu Pharmaceutical Co., Ltd, a subsidiary of Hisamitsu Pharmaceutical Co., Inc., is a Taiwanese company located in Taipei. The firm manufactures and markets pharmaceuticals.

Hanwha Chemical Co., Ltd., a subsidiary of Hanwha Corp., is a company headquartered in the South Korea that manufactures chemical products.

Ajou University Medical Center offers improvement of public health and the development of local communities.

MD Healthcare, Inc. is engaged in developing innovative precision medical solutions based on micro biome data. The company was founded in January, 2014 and is headquartered in Seoul, South Korea.

Nippon Kayaku produces and retails a range of chemicals. By product category, the company divides itself into four areas. Epoxy resins used as flame retardants in electronics, colorants, and dyes used in inkjet printers and materials for the production of textiles are sold by the functional chemicals segment, which is the one that generates the most income of any segment. Pharmaceutical companies market anti-cancer, biological, cardiovascular, vitamin, and anti-inflammatory medications. The automotive sector is supplied by the safety systems segment with airbag inflators and micro gas generators for seatbelt pre-tensioners, both of which are intended to protect passengers in the event of an accident. Insecticides and herbicides are offered for sale in the agrochemicals market.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Sylentis is a biotech company founded in 2006 and wholly owned by Pharma Mar S.A. (PHM:SM), with the mission of building a solid and sustainable business and becoming a leader of a new class of medicines based on RNA interference or RNAi. RNAi is a promising approach to silence targets involved in many diseases and represents a new drug mechanism of action. The Sylentis pipeline is aimed at indications with an elevated market potential, including ocular pathologies, inflammatory diseases and central nervous system diseases. Given the inherent complications of this technology regarding delivery of the active principle to the target tissue, our strategy is based on first selecting accessible therapeutic targets, which don not require systemic administration of the product. However, the development of formulations for RNAi technology to increase the therapeutic effect of these molecules is an area of great interest to the company

Jiangsu Suyuan Agricultural Technology Co., Ltd., established on 2010-01-12, Business scope includes fruit trees,the tea,vegetable,flowers,Seedling planting sales;poultry,animal husbandry,Aquaculture Sales;Packaging Materials,Manufacturing and sales of agricultural machinery;Agricultural greenhouse,Greenhouse development,processing,Install,Sales;Landscaping project planning,design,construction;crafts,department store sales;Agricultural tourism service;Information Technology Consulting Services;Agricultural Science and Technology Research and Development,Technology project promotion service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION provides practical help for improving the technology of an industrial field.

Nantong Fengchao Industrial Design Co., Ltd., established on 2017-03-31, Business scope includes industrial design;graphic design;Conference and Exhibition Services;Corporate Image Planning,Enterprise Marketing Planning;Technology development in the field of computer network technology,Technical Services,technical consulting,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xin Chao Bio is a supplier of medical diagnostic products. It is a high-tech enterprise focusing on providing accurate, fast and convenient medical diagnostic products. The company integrates the research and development, production and sales of in vitro diagnostic reagents, and has a complete industrial chain in the field of medical diagnostics. Relying on high-standard biological sample libraries, high-throughput tumor biochips and molecular marker screening and verification platforms with international brands, the company transforms high-tech basic and clinical research results into industries, develops and produces innovative in vitro diagnostic reagents, which are molecular testing and Pioneer in the molecular diagnostics industry.

Lipid Therapeutics GmbH develops therapies for inflammatory diseases of the digestive system. Its product is LT-02, a delayed release of Phosphatidylcholine, for the treatment of Ulcerative colitis based on the preclinical and clinical work conducted by Prof. Stremmel from the University Hospital Heidelberg. The company was founded in 2008 and is headquartered in Heidelberg, Germany.